To develop accurate and reliable treatment planning tools and methods for predicting the actual delivered dose to mobile tumours, together with the application of biological models for estimating treatment outcomes. The aim is therefore to implement a platform for decision support that presents the different treatment options with the expected therapeutic benefit to the physician taking into account the biological heterogeneity of tumours together with the potential effects of motion.